Jeffrey S. Ramsay

Davis Polk advised the sole initial purchaser in connection with a Rule 144A offering by The Medicines Company of $150 million aggregate principal amount of 3.50% convertible senior…

Davis Polk advised the underwriters in connection with the offering of $2.25 billion aggregate principal amount of 3.350% bonds due November 1, 2023, issued by the Province of Alberta. …

Davis Polk advised the underwriters in connection with the offering of $2.5 billion aggregate principal amount of 3.400% bonds due October 17, 2023, issued by the Province of Ontario…

Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of €250 million principal amount of senior secured notes due 2026 of WMG…

Davis Polk advised the representatives of the several underwriters in connection with the registered offering by DXC Technology Company of €650 million aggregate principal amount of 1…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1 billion aggregate principal amount of its 3.150% senior notes due 2020 and (ii) $1 billion aggregate…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Zoetis Inc. of $300 million aggregate principal amount of its floating-rate senior notes…

Davis Polk advised the representatives of the underwriters in connection with the $175.5 million offering of 2,700,000 shares of common stock of REGENXBIO Inc. The common stock is listed on…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $1.6 billion aggregate principal amount of its 3.500% senior notes due 2023 and (ii) $400 million…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $500 million aggregate principal amount of its 3.000% senior notes due 2020, (ii) $900 million…